Asked by: David Smith (Labour - North Northumberland)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he considered including people suffering from Long Covid within the Clinical risk group eligible for the covid-19 vaccination in the Autumn 2025 vaccination programme.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to protecting those most vulnerable to COVID-19 through vaccination, as guided by the independent Joint Committee on Vaccination and Immunisation (JCVI). The primary aim of the national COVID-19 vaccination programme remains the prevention of serious illness (hospitalisations and deaths) arising from COVID-19. Population immunity to COVID-19 has been increasing due to a combination of naturally acquired immunity following recovery from infection and vaccine-derived immunity. COVID-19 is now a relatively mild disease for most people, though it can still be unpleasant, with rates of hospitalisation and death from COVID-19 having reduced significantly since COVID-19 first emerged.
The focus of the JCVI advised programme has therefore moved towards targeted vaccination of the two groups who continue to be at higher risk of serious disease, including mortality. These are the oldest adults and individuals who are immunosuppressed.
On 13 November 2024, JCVI published advice on who should be offered vaccination in autumn 2025. On 26 June 2025, the Government accepted the JCVI’s advice that in autumn 2025, a COVID-19 vaccination should be offered to the following groups:
The Government has no plans to change eligibility for autumn 2025. It has accepted the JCVI advice for this campaign in full. As for all vaccines, the JCVI keeps the evidence under regular review.
Asked by: David Smith (Labour - North Northumberland)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has considered including lipedema as a relevant condition for NHS prescription of (a) Mounjaro injections and (b) other weight loss treatments.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Semaglutide, brand name Wegovy, tirzepatide, brand name Mounjaro, and liraglutide, brand name Saxenda, are approved for the management of obesity. They are recommended as cost-effective for use on the National Health Service for people who have a body mass index (BMI) over a certain threshold, and one or more weight-related comorbidities.
The marketing authorisations for tirzepatide and other weight loss medicines do not include an exhaustive list of qualifying comorbidities, and it is for the prescriber to apply their clinical judgement in determining whether a patient meets the eligibility criteria.
The exact causes of lipoedema are not clear, and the NHS.UK website states that it’s not caused by being overweight, and that it is a separate condition to obesity.
The NHS is currently rolling out tirzepatide in primary care, using a phased approach based on clinical need. Approximately 220,000 individuals are expected to be eligible over the next three years. NHS England worked with clinical experts, NHS integrated care boards, patient and public representatives, healthcare professionals, charities, and royal colleges on its prioritisation approach, which it set out in its interim commissioning guidance, at the following link:
At the current time, patients will be eligible for treatment in primary care if they have a BMI of at least forty, and four or more out of five ‘qualifying' conditions. The qualifying conditions for tirzepatide treatment are cardiovascular disease, hypertension, dyslipidaemia, obstructive sleep apnoea, and type 2 diabetes mellitus.
Asked by: David Smith (Labour - North Northumberland)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions he has had with (a) campaigners and (b) stakeholders on treatment for (i) lobular breast cancer and (ii) other rare cancers.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Improving outcomes and experiences of cancer treatment, including lobular breast cancer and other rare cancers, is a priority for the Government. Engagement with campaigners and partners is vital to achieving this.
My rt. Hon. Friend, the Secretary of State for Health and Social Care, accompanied by my hon. Friend, the Minister of State for Health, met with representatives of the Lobular Moonshot Project on 14 July 2025 to discuss their work. Following this meeting, the Chief Scientific Adviser and officials from the Department and the Medical Research Council (MRC) met again with the Lobular Moonshot Project to provide advice on existing funding options. Both the MRC and the National Institute for Health and Care Research have committed to continuing to work with the Lobular Moonshot Campaign team to support the development of fundable research proposals in this area and help drive our collective ambition to increase understanding and effective management of this disease.
In April 2025, I attended an event with Cancer Research UK, Macmillan, and Cancer52. The was followed by a roundtable in May 2025, in which I met with Cancer52 members, representing a wide range of cancer types, to discuss how the National Cancer Plan can prioritise rare cancers, to make a meaningful difference to how patients experience cancer treatment, and to bring cancer survivability back up to the standards of the best in the world. I have also met with brain cancer campaigners and All-Party Parliamentary Group members on several occasions since taking up post.
The National Cancer Plan will include more details about improving treatments for all tumour types, including lobular breast cancer. The Department continues to engage with a wide range of cancer partners on the Plan, including charities and patient representative bodies.
Asked by: David Smith (Labour - North Northumberland)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his policies of reports of Ulcerative Colitis and Crohn’s Disease not being eligible for free prescription charges as chronic health conditions.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
While the Department has made no assessment, approximately 89% of prescription items are dispensed free of charge in the community in England, and there is a wide range of exemptions from prescription charges already in place for which those with ulcerative colitis and Crohn’s disease may be eligible. Eligibility depends on the patient’s age, whether they are in qualifying full-time education, whether they are pregnant or have recently given birth, whether they have a qualifying medical condition, or whether they are in receipt of certain benefits or a war pension.
People on low incomes can apply for help with their health costs through the NHS Low Income Scheme. Prescription prepayment certificates (PPCs) are also available. PPCs allow people to claim as many prescriptions as they need for a set cost, with three-month and 12-month certificates available. The 12-month PPC can be paid for in instalments.
Asked by: David Smith (Labour - North Northumberland)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the Neighbourhood Health Service on dental services in rural constituencies.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
On 3 July 2025, the Government announced the 10-Year Health Plan and set out its vision for a Neighbourhood Health Service set up in local communities across the country, to improve access to National Health Services, including NHS dental services.
We expect neighbourhood teams and services to be designed in a way that reflects the specific needs of local populations. We will be clear on the outcomes we expect, and will give significant licence to tailor the approach to local need.
Our priority will be to address underperformance and health inequalities in the areas with the worst health outcomes, such as rural and coastal communities, where we know access to healthcare services is often particularly poor.
Asked by: David Smith (Labour - North Northumberland)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he has taken to support adult social care in rural areas.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Government recognises the challenges facing adult social care and is taking action to improve the system across the country, including in rural areas. We have launched an independent commission into adult social care as part of our critical first steps towards delivering a National Care Service, and are also taking forward a package of reforms to enable more people to live independently for longer.
We are also updating the Adult Social Care Relative Needs Formula for the first time since 2013/14 to ensure adult social care funding reflects an up-to-date assessment of need. Our proposals are set out in the Fair Funding Review 2.0 consultation document, a consultation on local government funding reform which sets out our plans for ensuring central Government funding is allocated to the places that need it most, ensuring the best value for money for the Government and taxpayers. This wider consultation includes proposals to more effectively account for variations in the relative cost and demand of delivering services between rural and urban areas. We are proposing to do this by considering the remoteness of an area alongside its accessibility in the Area Cost Adjustment.
Asked by: David Smith (Labour - North Northumberland)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the 10 year plan on older residents in rural areas.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The 10-Year Health Plan will ensure a better health service for everyone, regardless of condition or geography. The 10-Year Health Plan has been built on what we heard during engagement with the public. Our reimagined National Health Service will be designed to tackle inequalities in both access and health outcomes, and will ensure a better health service for everyone, regardless of age or geography.
The neighbourhood health service will reflect the specific needs of local populations, including the needs of older residents in rural communities. Neighbourhood health centres will be available in every community, providing easy access to NHS, local authority, and voluntary sector services. New technology-led services, including wearable and monitoring technology, will support patients such as older people with frailty to enable them to continue living independently in their own home.
Equality has been considered throughout, and we expect to publish an Equality Impact Assessment later this month.
Asked by: David Smith (Labour - North Northumberland)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the Neighbourhood Health Service on healthcare in rural constituencies.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Neighbourhood Health Service will mean millions of patients, including those in rural constituencies, are treated and cared for closer to their home by new teams of health professionals. Our priority will be to address underperformance and health inequalities in the areas with the worst health outcomes, such as rural and coastal communities, where we know access to healthcare services is often particularly poor.
We expect neighbourhood teams and services to be designed in a way that reflects the specific needs of local populations. While we will be clear on the outcomes we expect, we will give significant licence to tailor the approach to local need.
Our 10-Year Health Plan is creating a National Health Service truly fit for the future, keeping patients healthy and out of hospital, with care closer to home and in the home. An impact statement for the plan will be published in shortly.
Asked by: David Smith (Labour - North Northumberland)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the 10-year plan on waiting lists in the North East.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
We are committed to delivering the National Health Service constitutional standard that 92% of patients wait no longer than 18 weeks from referral to consultant-led treatment by March 2029, including in the North East and Yorkshire.
The 10-Year Health Plan sets out a transformed vision for planned care by 2035, where most interactions no longer take place in a hospital building, instead happening virtually, online, or via neighbourhood services. Planned care will be more efficient, timely, and effective, and will put control in the hands of patients.
By 2035, two thirds of outpatient care will take place digitally or in the community closer to home, with patients able to access the best of their local hospital in a much more responsive way via their phones. For patients who do need to be admitted, we will carry out more procedures as day cases and will reduce the time spent in hospital and recovery, as providers make greater use of surgical robots and innovations in anaesthetics and postoperative care.
Asked by: David Smith (Labour - North Northumberland)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the NHS is prepared for future demographic changes.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The 10-Year Health Plan sets out our plan to get the National Health Service back on track and make it fit for the future through delivering three big shifts in how the NHS works. By moving more care from hospital to community, shifting from analogue to digital, and reaching patients earlier by shifting from sickness to prevention, the NHS will be better enabled to meet future demographic changes.
Integrated care boards are expected to have a deep understanding of their population’s needs and will engage with the public to develop long-term plans that meet these needs.